Pylarify
Active Awarded Last action
- Contract number
- 36C25726N0316
- Awardee
-
Progenics Pharmaceuticals Inc. UEI YLYKVRPCTCR3 Part of Lantheus Holdings, Inc.
- Awarding agency
-
Veterans Integrated Service Network 17
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $721,744
Award facts
- Contract value 100% obligated
- $721,744.00 Current and potential, with all options
- Completion date 16% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Bedford, MA 01730, USA
Award details come from SAM.gov/FPDS.
About this award
Progenics Pharmaceuticals Inc., operating as a division of Lantheus Medical Imaging, Inc., received a $721,744 firm fixed-price delivery order from Veterans Integrated Service Network 17 on May 1, 2026, for the supply of PYLARIFY (piflufolastat F-18), a diagnostic radiopharmaceutical used in positron emission tomography imaging for prostate cancer detection and localization. The delivery order is scheduled for completion by April 30, 2029, and will be performed at the company's facility in Bedford, Massachusetts. This award represents a child contract issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) master vehicle and carries no set-aside designation.
This delivery order reflects Progenics' established role as a critical supplier of radiopharmaceutical products to the Veterans Health Administration, with the company having received over 150 federal contract awards across multiple VISNs and the Defense Health Agency. The award is positioned within a broader procurement framework that includes a $290 million Federal Supply Schedule contract awarded to the company in April 2025, enabling the VA system to efficiently procure specialized nuclear medicine supplies supporting oncology diagnostic imaging programs across federal healthcare facilities serving veterans and military personnel.
Quick answers
Who was awarded contract 36C25726N0316?
36C25726N0316 was awarded to Progenics Pharmaceuticals Inc. by Veterans Integrated Service Network 17 (Veterans Health Administration) on May 1, 2026.
How much is contract 36C25726N0316 worth?
The government has obligated $721,744 on 36C25726N0316.
Is contract 36C25726N0316 an order under another contract?
Yes. 36C25726N0316 is a delivery order under 36F79725D0093, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C25726N0316 competed?
The extent of competition for 36C25726N0316 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award